Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma

Name: Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
License: Public Domain

Bristol-Myers Squibb

ClinicalTrials.gov · Datasets · License: Public Domain

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 290980
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.